Target intelligence / Profile preview

Bacterial DNA-directed RNA polymerase subunit beta (RpoB) (RpoB)

Target
RpoB
Molecular classification
Enzyme, Transferase, DNA-directed RNA polymerase
01

Overview

The bacterial DNA-directed RNA polymerase (RNAP) beta subunit is a core catalytic component of the enzyme responsible for synthesizing RNA from a DNA template. A central feature of this subunit is its contribution to the DNA/RNA channel (also known as the main channel), which houses the DNA template and the nascent RNA-DNA hybrid during transcription elongation (UniProt Consortium, 2023). This channel is a vital therapeutic target because its occlusion or the stabilization of its mobile elements can halt the transcription process entirely. Rifamycins, the most prominent class of drugs targeting this subunit, bind near the active site within the RNA exit path, effectively acting as a "plug" that prevents the RNA transcript from extending beyond a few nucleotides (Campbell et al., 2001). Newer inhibitors like salinamides specifically target the DNA/RNA channel to interfere with the enzyme's translocation along the DNA (Degen et al., 2014). Targeting this site provides high selectivity for bacterial pathogens over human cells due to structural divergence in the polymerase subunits (Villain-Guillot et al., 2007). Resistance to these drugs is a major clinical concern and usually arises from mutations in the rpoB gene that modify the architecture of the channel or binding pocket (Goldstein, 2014).

Other names
RNA polymerase beta subunitDNA-directed RNA polymerase subunit betaRNAP beta subunitrpoBBacterial RNA polymerase beta subunit
02

Mechanism of action

Inhibition of bacterial transcription by binding to the beta subunit and sterically blocking the RNA exit channel or the DNA/RNA main channel, thereby preventing RNA chain elongation (Campbell et al., 2001; Degen et al., 2014).

03

Biological functions

TranscriptionRNA synthesisGene expression regulation
04

Disease associations

InfectionTuberculosisLeprosyMeningitisEndocarditis
05

Safety considerations

HepatotoxicityCytochrome P450 induction (leading to significant drug-drug interactions)Rapid development of antibiotic resistanceGastrointestinal distress
06

Interacting drugs

Rifampin

5 more in the full profile.

07

Biomarkers

rpoB gene mutationsSputum culture conversionMolecular drug susceptibility testing (e.g., GeneXpert)

Beyond the preview

Go deeper on Bacterial DNA-directed RNA polymerase subunit beta (RpoB) (RpoB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial DNA-directed RNA polymerase subunit beta (RpoB) (RpoB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call